Dr. Stanton is a seasoned drug discovery leader and formed Director of Discovery Biology at Herophilus with experience in organoid models and disease phenotyping. She has a Ph.D. in Chemistry from Worcester Polytechnic Institute and completed her Postdoc at the Max Planck Institute for Intelligent Systems in Germany.

Dr. Taylor is Prof. of Reproductive Sciences as well as Prof. of Molecular, Cellular and Developmental Biology at Yale School of Medicine. He has decades of experience treating patients with endometriosis and fibroids and has served as president of the Society for Reproductive Investigation.

Dr. Mosivais is Prof. of Pathology and Immunology at Baylor College of Medicine. She is a leader in women’s reproductive research, developing 3D uterine organoid cultures and genetic mouse models to study pregnancy complications, endometriosis and endometrial cancer.

Dr. Lundeen was Head of the Reproductive Therapeutic Discovery Team at Johnson & Johnson and has spend 17+ years at the J&J Innovative Medicine Business Development. He has executed deals for programs from all stages of discovery and development - target identification through Phase 3 trials.

Dr. Shariff has numerous patents and publications with a key focus in Generative AI for DNA/protein sequence design and Image-based phenotyping. He has spent more than a decade working in the biotech industry leading several teams at start-ups with successful exits and at Fortune 500 companies.

Alexia holds an MBA from UC Berkeley and currently serves as an advisor at Berkeley SkyDeck. Previously, as a biotech COO, she spearheaded strategic corporate partnerships that successfully raised over $40+ million in start-up funding. Alexia is passionate about building, “things that leave a footprint in the world, improve lives, and push the boundaries of what's possible.”